Two researchers from Mater Research Institute UQ (MRI-UQ) have been honoured in The University of Queensland’s annual Research Awards.
Associate Professor Ingrid Winkler received the Partner in Research Excellence Award for her work exploring new approaches to alleviating side effects of cancer therapy.
Her collaborative research investigated a novel strategy to improve treatment and outcomes for leukaemia patients, a project which attracted the sponsorship of GlycoMimetics for a clinical trial.
"Median survival rates for adults with acute myeloid leukaemia remains at only 16 months so new treatment strategies are desperately needed,” Associate Professor Winkler said.
Dr Sumaira Hasnain was awarded the Foundation Research Excellence Award for her work targeting cellular stress in autoimmune diabetes.
“It is all about relieving stress on the cells that produce insulin – the hormone responsible for regulating blood sugar levels,” Dr Hasnain said.
“I’m researching a protein released by white blood cells naturally which may restore insulin production, and whether we can use this as a preventative measure or as a treatment for diabetes.”
Deputy Vice-Chancellor (Research) and Acting Executive Dean, Faculty of Medicine, Professor Robyn Ward said the awards gave a snapshot of UQ’s breadth and depth of research, from early to mid-career researchers to industry collaborators and RHD supervisors.
“This is a fantastic opportunity to recognise our exceptional researchers and research mentors, all of whom are creating positive change for people locally, nationally and internationally,” Professor Ward said.
Last night’s UQ Research Awards are a highlight of Research Week, which aims to raise awareness of UQ research in the wider community.
Associate Professor Ingrid Winkler:
Dr Sumaira Hasnain:
Media: Bernadette O’Connor, firstname.lastname@example.org, +61 7 3365 1188, 0431 533 209